the ict rewarding success is expected to:

1. incentivize multidisciplinary research teams and their healthcare and innovation partners to design, adopt, and evaluate interventions implemented into a healthcare delivery organization that enhance value-based care, health system sustainability, and health outcomes.
2. support innovative process transformations that improve health outcomes and value for canada’s healthcare investment.

in canada, the dramatic and increasing number of overdoses and deaths related to the use of opioids is a national public health crisis. the government of canada is committed to tackling this crisis and has emphasized the need for a strong evidence base through the canadian drugs and substances strategy (cdss), and the joint statement of action to address the opioid crisis. this funding opportunity will support expedited knowledge synthesis grants to rapidly inform policies on opioids related to one or more pillars of cdss (i.e. prevention, treatment, harm reduction and enforcement).

knowledge syntheses are the cornerstone of knowledge translation. they interpret vast libraries of scientific literature into knowledge that is reliable, relevant and readable for knowledge users. syntheses are comprehensive and apply scientific methods to literature analysis which minimizes the risk of bias and error that may accompany single studies, so health policy and practice decisions are less likely to be based on insufficient or premature evidence. syntheses are also a means to integrate established literature with other forms of knowledge, to map the state of current knowledge on a topic, revealing to knowledge users where there is or is not strong evidence to inform their decisions, or to guide researchers to new areas of research.

this funding opportunity is expected to:

• address the pressing evidence needs of knowledge users within one or more pillars of the cdss.
• increase the application of knowledge related to one or more pillars of the cdss in policy and decision-making, in order to address the most urgent elements of the opioid crisis, including opioid-related mortality rates.
• encourage syntheses that consider sub-populations and/or the biological and social determinants of problematic opioid use.

the objective of the economic forecasting funding opportunity is to:

• advance knowledge in health economic forecasting of the cost of primary and secondary prevention, and early intervention services.
• build capacity to produce financial projections that would more easily allow government departments to understand the impact of scaling evidence-based primary and secondary prevention interventions on their budgets over time

the specific objectives of this funding opportunity are:

• to add value to the current state of basic biomedical knowledge on a given topic that has potential to, but has not yet fully elucidated, the impact of sex on biological mechanisms or pathophysiology.
• to promote increased awareness, knowledge and self-efficacy among biomedical researchers regarding the integration of sex as a variable in their research.
• to contribute to the improvement of women and men’s health in canada and the world.

the st. joseph’s care group (sjcg) award in applied health research is available to a full-time graduate student at 阿根廷vs墨西哥竞猜 pursuing research related to the service areas of sjcg. the service areas are: addictions & mental health, rehabilitative care & chronic disease management, and seniors’ health. more information can be found at www.sjcg.net. the recipient of the award must be a canadian citizen or permanent resident of canada, and be residing in thunder bay during the tenure of the award. the recipient must be working with a supervisor who is a member of the centre for applied health research (cahr) at sjcg. in addition, the recipient must not hold another major award/scholarship (valued at $15,000 or greater). the award is administered through the cahr at sjcg and is valued at $10,000 from december 1, 2017 to august 31, 2018. information about the cahr is available at www.cahr.sjcg.net.

application documents are available by contacting carrie gibbons at gibbonsc@tbh.net.

deadline: october 31, 2017

the objective of this cfp is to invite eligible organizations to submit proposals for projects which support the development of skills to meet the demands of canada’s labour market or address labour market issues by supporting the production, dissemination and application of one or more of the following:

1. labour market information
2. national occupation standards/competency frameworks
3. certification programs
4. accreditation systems

in addition to these project types, projects with activities related to creative solutions that provide new ways of addressing sector-specific labour market issues may also be considered.

grants available: 

• idea development award
• epilepsy risk factors award

letters of intent due september 21.

fy17 prarp program announcements and general application instructions for the following award mechanisms are posted on grants.gov. 

the prarp’s mission is devoted to (1) understanding the association between traumatic brain injury (tbi) and alzheimer’s disease (ad)/alzheimer’s disease-related dementias (adrd) and (2) reducing the burden on affected individuals and caregivers, especially in the military and veteran communities.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate, manages the defense health program research, development, test, and evaluation appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy17 prarp overarching challenges and focus areas:

all applications for the fy17 prarp funding opportunities must address at least one of the following fy17 overarching challenges. the fy17 overarching challenges may be mechanism-specific.

the prarp fy17 overarching challenges are listed below.

in addition to addressing one or more of the specified fy17 overarching challenges, applications should also address at least one of the following fy17 focus areas in support of the fy17 overarching challenges.  an application that proposes research outside of the fy17 focus areas is acceptable, as long as the applicant provides a strong rationale.  the focus areas will be mechanism-specific.

the prarp fy17 focus areas are listed below.

the following is a summary of the fy17 prarp program announcements.  four award mechanisms will be offered for fy16.  this pre-announcement should not be construed as an obligation by the government.

http://cdmrp.army.mil/funding/prarp

convergence science research award – letter of intent due september 21, 2017

the principal investigator (pi) must be  at or above the level of assistant professor (or equivalent).

intent:  support efforts to generate research resources, tools, or novel research efforts for researchers and/or practitioners in health sciences.

applications must address one or more of the following fy17 prarp overarching challenges:

·         paucity of research resources

·         paucity of clinical studies

·         diagnostic technologies, tests, biomarkers, or devices

·         epidemiology

applications should address at least one of the following fy17 prarp focus areas:

·         genomics/proteomics

·         mechanisms of pathogenesis

·         biomarkers

·         novel target identification

·         epidemiological research

research considering pharmacologic interventions is specifically discouraged under this mechanism.

preliminary data, while not required, are encouraged.

• maximum funding is $500,000 for direct costs (plus indirect costs).
• maximum period of performance is 3 years.
• indirect costs may be proposed in accordance with the institution's rate agreement.

quality of life research award – letter of intent due september 21, 2017

the pi must be an independent investigator at or above the level of assistant professor (or equivalent).

intent:  the intent of the research funded through this award is to (1) support research to alleviate, stabilize, or characterize the symptoms or deficits common to tbi,  ad, and adrd and (2) reduce the burden of care on the caregivers for individuals living with the common symptoms of tbi and ad/adrd.  research may be proposed to either facet of the intent.  both are equally important.

applications must address one or more of the following fy17 prarp overarching challenges:

·         paucity of clinical studies

·         epidemiology

·         quality of life

·         caregiver burden

applications should address at least one of the following fy17 prarp focus areas:

·         quality of life

·         caregiver support

·         biomarkers

·         epidemiological research

research considering pharmacologic interventions is specifically discouraged under this mechanism.

preliminary data, while not required, are encouraged.

·         funding limit is $500,000 in direct costs.

·         maximum period of performance is 3 years.

·         indirect costs may be proposed in accordance with the institution's rate agreement.

new investigator award

the pi must be an independent, early-career investigator within 4 years of his/her first independent faculty position (or equivalent).

intent: support early-career investigators interested in novel research efforts or new technologies addressing tbi and ad/adrd.

applications must address one or more of the following fy17 prarp overarching challenges:

·         paucity of research resources

·         paucity of clinical studies

·         diagnostic technologies, tests, biomarkers, or devices

·         epidemiology

·         quality of life

·         caregiver burden

applications should address at least one of the following fy17 prarp focus areas:

·         genomics/proteomics

·         mechanisms of pathogenesis

·         biomarkers

·         quality of life

·         caregiver support

·         epidemiological research

·         novel target identification

research considering pharmacologic interventions is specifically discouraged under this mechanism.

preliminary data, while not required, are encouraged.

• funding limit is $225,000 in direct costs.
• maximum period of performance is 3 years.
• indirect costs may be proposed in accordance with the institution’s rate agreement.

research partnership award – letter of intent due september 21, 2017

the pi must be an independent investigator  at or above the level of assistant professor (or equivalent),

intent:  to create an avenue for collaborative research partnerships between investigators to address a research problem or question in a manner that would be unachievable through separate efforts.

applications must include clearly stated plans for interactions between the partners.  the plans must include communication, coordination or research progress and results, and data sharing between all investigators and organizations participating in the project.

applications must address one or more of the following fy17 prarp overarching challenges:

·         paucity of research resources

·         paucity of clinical studies

·         diagnostic technologies, tests, biomarkers, or devices

·         epidemiology

·         quality of life

·         caregiver burden

applications should address at least one of the following fy17 prarp focus areas:

·         genomics/proteomics

·         mechanisms of pathogenesis

·         biomarkers

·         quality of life

·         caregiver support

·         epidemiological research

·         novel target identification

research considering pharmacologic interventions is specifically discouraged under this mechanism.

preliminary data are required.

• funding limit is $1.3 million in total costs.
• maximum period of performance is 3 years.
• indirect costs may be proposed in accordance with the institution’s rate agreement.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions that are available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

applications must be submitted through the federal government’s single-entry portal, grants.gov.  for email notification when program announcements are released, go to the cdmrp website (http://cdmrp.army.mil) and select subscribe to funding opportunities & program communications.  for more information about the prarp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org